Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$90.20−1.24 (-1.36%)
Close on Nov 12, 2026Market cap $7.08BP/E –Yield –
Abivax enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Abivax's enterprise value was $6.87B on Nov 11, 2026, against $7.19B a year earlier. Over the last 3 years it ranged from $113.60M to $10.02B, with a median of $627.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.87B | -12.1% |
| 2025 | Dec 31, 2025 | $7.81B | +3809.5% |
| 2024 | Dec 31, 2024 | $199.77M | -4.3% |
| 2023 | Dec 29, 2023 | $208.81M | – |
See a number that looks wrong?